Spots Global Cancer Trial Database for thromboembolism
Every month we try and update this database with for thromboembolism cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE) | NCT03099031 | Venous Thromboe... | Tinzaparin | 18 Years - | LEO Pharma | |
Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a Vein | NCT00964275 | Thromboembolism Unspecified Adu... | diagnostic proc... fludeoxyglucose... | 18 Years - | University Hospital, Brest | |
Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients | NCT04301362 | Cancer Thromboembolism Thrombosis Biomarkers | Thrombosis biom... | 18 Years - | Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. | |
Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters | NCT00024297 | Thromboembolism | warfarin | 16 Years - | National Cancer Institute (NCI) | |
The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer | NCT05178628 | Pancreatic Canc... Thromboembolism | Innohep Chemotherapy: G... | 18 Years - | Institute of Molecular Medicine and Biomedical Research | |
Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®) | NCT00400504 | Cancer | 18 Years - | Rigshospitalet, Denmark | ||
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL) | NCT03098589 | Lymphoma | Revlimid | 18 Years - | Celgene | |
Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica" | NCT03855592 | Thromboembolism Cancer | 18 Years - | Fundación Sociedad Española de Oncologia Médica | ||
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | NCT00020189 | Head and Neck C... Thromboembolism | acetylsalicylic... alvocidib clopidogrel bis... | 18 Years - | National Cancer Institute (NCI) | |
Dalteparin in Preventing Blood Clots in Patients With Lung Cancer | NCT00519805 | Lung Cancer Thromboembolism | dalteparin quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
Atrial Fibrillation and Cancer: a Nationwide French Cohort Study | NCT05563883 | Atrial Fibrilla... Cancer Thromboembolism Bleeding | event occurence | 18 Years - | University Hospital, Caen | |
Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology | NCT01696760 | Bone Metastases Musculoskeletal... Soft Tissue Sar... Thromboembolism | acetylsalicylic... enoxaparin PCD | 18 Years - | Ohio State University Comprehensive Cancer Center | |
Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery | NCT00096590 | Thromboembolism Unspecified Adu... | coagulation stu... immunoenzyme te... laboratory biom... physiologic tes... study of high r... | 18 Years - | National Cancer Institute (NCI) | |
Thromboprophylaxis in Oesophageal Cancer Patients | NCT05067153 | Esophageal Neop... Thrombosis Thromboembolism | Fragmin 5000 UN... | 18 Years - | University of Aarhus | |
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer | NCT00381888 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Thromboembolism Vaginal Cancer Vulvar Cancer | fondaparinux so... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery | NCT05957822 | Arthritis Knee Spine Fusion Prostate Cancer Arthritis of Hi... Hepatic Cancer | TXA TEG6 | 19 Years - | Konkuk University Medical Center | |
Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica" | NCT03855592 | Thromboembolism Cancer | 18 Years - | Fundación Sociedad Española de Oncologia Médica | ||
Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery | NCT05957822 | Arthritis Knee Spine Fusion Prostate Cancer Arthritis of Hi... Hepatic Cancer | TXA TEG6 | 19 Years - | Konkuk University Medical Center | |
Coagulation System In STereotactic Radiotherapy Of NSCLC | NCT03893461 | Thromboembolism Lung Cancer NSCLC Radiotherapy; C... | x | 18 Years - | Odense University Hospital | |
Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism | NCT00423683 | Cancer Thromboembolism | Arixtra alone Arixtra + filte... | 18 Years - | Northwell Health | |
Tranexamic Acid in Surgery of Advanced Ovarian Cancer | NCT00740116 | Ovarian Cancer | Tranexamic acid 0.9% NaCl solut... | 18 Years - | University Hospital, Linkoeping | |
Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms | NCT06065592 | Cancer Solid Tumor Thromboembolism Cardiovascular ... Immune System D... Inflammatory Di... Colon Cancer Breast Cancer Prostate Cancer Hepatocellular ... Lung Cancer Chemotherapy Immunotherapy | Palbociclib Rivaroxaban SNP | 18 Years - | Lebanese University | |
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer | NCT00014352 | Prostate Cancer Thromboembolism | docetaxel doxorubicin hyd... estramustine ph... ketoconazole warfarin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer | NCT00662688 | Chemotherapeuti... Pancreatic Canc... Thromboembolism | daltéparine Chemotherapy at... | 18 Years - 80 Years | GERCOR - Multidisciplinary Oncology Cooperative Group | |
Long-term Active Surveillance Study for Oral Contraceptives (LASS) | NCT00676065 | Arterial Thromb... Venous Thromboe... Breast Cancer | - | Center for Epidemiology and Health Research, Germany | ||
Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®) | NCT00400504 | Cancer | 18 Years - | Rigshospitalet, Denmark | ||
Coagulation System In STereotactic Radiotherapy Of NSCLC | NCT03893461 | Thromboembolism Lung Cancer NSCLC Radiotherapy; C... | x | 18 Years - | Odense University Hospital | |
Thromboembolic Risk Screening in Patients With Cancer and COVID-19 | NCT04616846 | Neoplasms Malig... Covid19 Thromboembolism | Peripheral veno... | 18 Years - | Centre Antoine Lacassagne | |
Thromboembolic Risk Screening in Patients With Cancer and COVID-19 | NCT04616846 | Neoplasms Malig... Covid19 Thromboembolism | Peripheral veno... | 18 Years - | Centre Antoine Lacassagne | |
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer | NCT00031837 | Pancreatic Canc... Thromboembolism | dalteparin gemcitabine hyd... quality-of-life... | 18 Years - 120 Years | University of Rochester | |
Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy | NCT01132833 | Multiple Myelom... Plasma Cell Neo... Thromboembolism | enzyme-linked i... laboratory biom... medical chart r... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms | NCT06065592 | Cancer Solid Tumor Thromboembolism Cardiovascular ... Immune System D... Inflammatory Di... Colon Cancer Breast Cancer Prostate Cancer Hepatocellular ... Lung Cancer Chemotherapy Immunotherapy | Palbociclib Rivaroxaban SNP | 18 Years - | Lebanese University | |
Tranexamic Acid in Surgery of Advanced Ovarian Cancer | NCT00740116 | Ovarian Cancer | Tranexamic acid 0.9% NaCl solut... | 18 Years - | University Hospital, Linkoeping | |
Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery | NCT00096590 | Thromboembolism Unspecified Adu... | coagulation stu... immunoenzyme te... laboratory biom... physiologic tes... study of high r... | 18 Years - | National Cancer Institute (NCI) | |
Thromboembolic Risk Screening in Patients With Cancer and COVID-19 | NCT04616846 | Neoplasms Malig... Covid19 Thromboembolism | Peripheral veno... | 18 Years - | Centre Antoine Lacassagne | |
Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a Vein | NCT00964275 | Thromboembolism Unspecified Adu... | diagnostic proc... fludeoxyglucose... | 18 Years - | University Hospital, Brest | |
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | NCT00020189 | Head and Neck C... Thromboembolism | acetylsalicylic... alvocidib clopidogrel bis... | 18 Years - | National Cancer Institute (NCI) | |
TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer | NCT05625932 | Colorectal Canc... Thromboembolism | Tinzaparin | 18 Years - | Galician Research Group on Digestive Tumors | |
Atrial Fibrillation and Cancer: a Nationwide French Cohort Study | NCT05563883 | Atrial Fibrilla... Cancer Thromboembolism Bleeding | event occurence | 18 Years - | University Hospital, Caen | |
The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer | NCT05178628 | Pancreatic Canc... Thromboembolism | Innohep Chemotherapy: G... | 18 Years - | Institute of Molecular Medicine and Biomedical Research | |
Coagulation Profile in Patients Undergoing Video Assisted Thorascopic Surgery (VATS) for Lung Cancer | NCT01741506 | Lung Cancer | Dalteparin (Fra... | 18 Years - | Aarhus University Hospital | |
A Study to Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism and Cancer | NCT05643885 | Thromboembolism | 18 Years - | Pfizer | ||
Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®) | NCT00400504 | Cancer | 18 Years - | Rigshospitalet, Denmark | ||
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL) | NCT03098589 | Lymphoma | Revlimid | 18 Years - | Celgene | |
Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a Vein | NCT00964275 | Thromboembolism Unspecified Adu... | diagnostic proc... fludeoxyglucose... | 18 Years - | University Hospital, Brest | |
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg | NCT02921828 | Multiple Myelom... | 18 Years - | Celgene | ||
Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Risk Factors for Thromboembolism | NCT04246073 | Cancer Cancer Diagnosi... Thromboembolism | 18 Years - | Hellenic Society of Surgical Oncology | ||
Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | NCT00462852 | Pancreatic Canc... Thromboembolism | dalteparin gemcitabine hyd... diagnostic labo... | 18 Years - | National Cancer Institute (NCI) |